NEW YORK (GenomeWeb News) - QuantumBio said yesterday that it has been awarded a Small Business Innovation Research grant worth more than $865,000 from the National Institutes of Health to develop molecular modeling software tools.
The two-year Phase II SBIR project will focus on developing quantum mechanics-based methods for studying protein/drug interactions. These methods “will ultimately lead to next generation molecular modeling tools used to aid pharmaceutical companies in developing more potent, less expensive drugs and drug-like compounds,” the company said in a statement.
In the first phase of the project, the company developed several novel interaction determination methods, which it validated against a number of enzyme targets. The Phase II project will focus on validating these methods with pharmaceutical industry partners, the company said.